Cell-state plasticity drives heterogeneity in Group 3/4 medulloblastoma
Piyush K. JoshiiD, Patricia Benites Goncalves da SilvaiD, Konstantin OkonechnikoviD, Tamina Stelzer, Ioannis SarropoulosiD, Mari SeppiD, Jana Nolle, Mischan Vali Pour-Jamnani, Anne RademacheriD, Tetsuya Yamada-Saito, Celine SchneideriD, Julia SchmidtiD, Luca BianchiniiD, Philipp Sven Lars SchäferiD, Kevin LeissiD, Michele BortolomeazziiD, Jan‐Philipp MallmiD, Britta Statz, Andrea Wittmann, Kathrin SchrammiD, Mirjam Blattner-JohnsoniD, Petra Fiesel, Barbara JonesiD, Till MildeiD, Kristian W. PajtleriD, , Lena M. KutscheriD
Abstract
Cellular heterogeneity in Group 3 and Group 4 medulloblastomas is a major driver of therapeutic intractability. Here, we describe transcription factor-driven mechanisms underlying cellular diversity in these tumors using a comprehensive single-nucleus multi-omics atlas. Our analysis reveals that rather than fixed entities, these tumors exist along a continuum of cell states defined by four molecular identity axes. We show that perturbing transcription factor activity drives cellular plasticity, a key contributor to tumor heterogeneity. Strikingly, modulation of the lineage determinant PAX6 redirects tumor cells along both Group 3- and Group 4-like differentiation trajectories, modeling a bi-lineage medulloblastoma, and reduces aggressiveness of MYC-driven tumor models. Together, our findings reveal how oncogenic signals co-opt cerebellar unipolar brush cell programs to rewire tumor cell states and identify cellular plasticity as a potential targetable vulnerability in medulloblastoma.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Notch1 switches progenitor competence in inducing medulloblastoma
L. Tiberi·bioRxiv·May 10, 2020
- Medulloblastoma oncogene aberrations are not involved in tumor initiation, but essential for disease progression and therapy resistance
Konstantin Okonechnikov, Piyush K. Joshi, … Stefan Michael Pfister·NaturePeer-reviewed·May 7, 2025
- Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis
- Medulloblastoma Group 3 and 4 Tumors Comprise a Clinically and Biologically Significant Expression Continuum Reflecting Human Cerebellar Development
D. Williamson, E. C. Schwalbe, … S. C. Clifford·bioRxiv·Jun 9, 2022
- Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition
Tuan Vo, Brad Balderson, … Laura A. Genovesi·Genome MedicinePeer-reviewed·May 1, 2023
- Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage
D. R. Ghasemi, K. Okonechnikov, … K. W. Pajtler·Nature CommunicationsPeer-reviewed·Jan 8, 2024